Home Biosimilar Antibodies Others Others Nipocalimab (Anti-FcRn) (FCGRT & B2M) For research use only.
Not for use in humans.

Nipocalimab (Anti-FcRn) (FCGRT & B2M)

Synonyms: M281

Nipocalimab (anti-FcRn) (FCGRT & B2M) is a fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. MW: 142.12 KD.

Nipocalimab (Anti-FcRn) (FCGRT & B2M)

Purity & Quality Control

≥99

Biological Activity

Description Nipocalimab (anti-FcRn) (FCGRT & B2M) is a fully human monoclonal antibody that targets the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. MW: 142.12 KD.

Product Details

CAS No. 2211985-36-1
Molecular Weight 142.12
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Nipocalimab (Anti-FcRn) (FCGRT & B2M) | Nipocalimab (Anti-FcRn) (FCGRT & B2M) supplier | purchase Nipocalimab (Anti-FcRn) (FCGRT & B2M) | Nipocalimab (Anti-FcRn) (FCGRT & B2M) cost | Nipocalimab (Anti-FcRn) (FCGRT & B2M) manufacturer | order Nipocalimab (Anti-FcRn) (FCGRT & B2M) | Nipocalimab (Anti-FcRn) (FCGRT & B2M) distributor